Cancer Drug Fund Increased
Thursday, August 28, 2014
Earlier this year, the coalition government announced that it would extend the Cancer Drugs Fund (CDF) until 2016, meaning an additional £200 million a year would be given to the NHS.
Today the Rt Hon Jeremy Hunt MP announced a further change to the fund. For the next two years the CDF will receive an extra £80 million a year to improve patient access to cancer drugs.
Professor Peter Clark (chair of the CDF) has written to Simon Stevens (Chief Executive of NHS England) to recommend that the CDF’s panel of experts re-evaluates the drugs on the National Cohort Policy List, some of which he suggests have little clinical benefit. Simon Stevens said “within this extra funding we want to ensure the drugs provide maximum benefits to patients and that the CDF incentivizes responsible pricing by drug companies.”
The fund has benefited more than 55,000 cancer patients since 2010, giving 2000 people access to treatments every month that they otherwise would not have received through the NHS. These recent announcements have reignited discussion around the CDF and how it is not sustainable as a long-term solution to the problem of access to drugs that currently exists in the